Myelin contains neutral sphingomyelinase activity that is stimulated by tumor necrosis factor-α

Journal of Neuroscience Research

Volumn 50, Issue 3, 1997, Pages 466-476

  Chakraborty, G ^a   Ziemba, S ^a   Drivas, A ^a   Ledeen, R W ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Ceramide; Cholesterol ester; Demyelination mechanism; Myelin; Myelin localized enzymes; Signal transduction in myelin; Sphingomyelin; Sphingomyelinase; Tumor necrosis factor; Tumor necrosis factor receptor

Indexed keywords

CHOLESTEROL ESTER; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; DEMYELINATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; LIPID METABOLISM; MOUSE; MYELINATION; NONHUMAN; PRIORITY JOURNAL; PROTEINASE INHIBITION; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION;

ACETATES; ANIMALS; BRAIN; BRAIN STEM; CELL FRACTIONATION; CERAMIDES; CHOLESTEROL ESTERS; CHOLINE; DIGLYCERIDES; ISOENZYMES; KINETICS; MAGNESIUM; MICE; MYELIN SHEATH; PHOSPHATIDYLCHOLINES; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030694454     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19971101)50:3<466::AID-JNR13>3.0.CO;2-4     Document Type: Article

References (60)

1. Bazzoni F, Beutler B (1996): The tumor necrosis factor ligand and receptor families. N Engl J Med 334:1717-1725.
2. Berti-Mattera LN, Douglas JG, Mattera R, Goraya TY (1992): Identification of G protein subtypes in peripheral nerve and cultured Schwann cells. J Neurochem 59:1729-1735.
3. Boulias C, Moscarello MA (1989): Guanine nucleotides stimulate hydrolysis of phosphatidylinositol bisphosphate in human myelin membranes. Biochem Biophys Res Commun 162:282-287.
4. Braun PE, Horvath E, Yong VW, Bernier L (1990): Identification of GTP-binding proteins in myelin and oligodendrocyte membranes. J Neurosci Res 26: 16-23.
5. Brosnan CF, Raine CS (1996): Mechanisms of immune injury in multiple sclerosis. Brain Pathol 6:243-257.
6. Brosnan CF, Selmaj K, Raine CS (1988): Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J Neuroimmunol 18:87-94.
7. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV (1996): Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383:716-719.
8. Casadó V, Mallol J, Lluis C, Franco R, Canela E (1991): Adenosine receptors in myelin fractions and subfractions: the effect of the agonist (R)-phenylisopropyladenosine on myelin membrane microviscosity. J Neurochem 57:1623-1629.
9. Chakraborty G, Ledeen RW (1993): Guanylyl cyclase activity in rat brain myelin and white matter. J Neurochem 61:1953-1956.
10. Chakraborty G, Ziemba S, Ledeen RW (1995): Signal transduction induced by TNF-α promotes cholester ester formation in mouse brain. J Neurochem 64(suppl):S61B.
11. Chao MV (1995): Ceramide: a potential second messenger in the nervous system. Molec Cell Neurosci 6:91-96.
12. Chatterjee S (1994): Neutral sphingomyelinase action stimulates signal transduction of tumor necrosis factor-α in the synthesis of cholesterol ester in human fibroblasts. J Biol Chem 269:879-882.
13. Choi MU, Suzuki K (1978): A cholesterol-esterifying enzyme in rat central nervous system myelin. J Neurochem 31:879-885.
14. Deshmukh DS, Bear WD, Brockerhoff H (1978): Polyphosphoinositide biosynthesis in three subfractions of rat brain myelin. J Neurochem 30:1191-1193.
15. Deshmukh DS, Kuizon S, Bear WD, Brockerhoff H (1982): Polyphosphoinositide mono- and diphosphoesterases of three subfractions of rat brain myelin. Neurochem. Res. 7:617-626.
16. NTR with Trk receptors. J Biol Chem 270:22135-22142.
17. Eisenthal R, Cornish-Bowden A (1974): The direct plot: a new graphical procedure for estimating enzyme kinetic parameters. Biochem J 139:715-720.
18. Eng LF, Ghirnikar RS, Lee YL (1996): Inflammation in EAE: role of chemokine/cytokine expression by resident and infiltrating cells. Neurochem Res 21:511-525.
19. Eto Y, Suzuki K (1972): Cholesterol esters in developing rat brain: concentration and fatty acid composition. J Neurochem 19:109-115.
20. Gatt S (1976): Magnesium-dependent sphingomyelinase. Biochem Biophys Res Commun 68:235-241.
21. Gordon HM, Kucera G, Salvo R, Boss J (1992): Tumor necrosis factor induces genes involved in inflammation, cellular and tissue repair, and metabolism in murine fibroblasts. J Immunol 148: 4021-4027.
22. Grabow M, Chakraborty G, Ledeen RW (1996): Characterization of guanylyl cyclase in purified myelin. Neurochem Res 21:457-462.
23. Haley JE, Samuels FG, Ledeen RW (1981): Study of myelin purity in relation to axonal contaminants. Cell Mol Neurobiol 1:175-187.
24. Hannun YA (1994): The sphingomyelin cycle and second messenger function of ceramide. J Biol Chem 269:3125-3128.
25. Horrocks JA (1968): Composition of mouse brain myelin during development. J Neurochem 15:483-488.
26. Jagannatha HM, Sastry PS (1981): Ethanolamine plasmalogen and cholesterol ester metabolism in experimental allergic encephalomyelitis. Ind J Biochem Biophys 18:411-416.
27. Jarvis WD, Kolesnick RN, Fornari FA, Traylor RS, Gewirtz DA, Grant S (1994): Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci USA 91:73-77.
28. Kim M-Y, Linardic C, Obeid L, Hannun Y (1991): Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor a and γ-interferon. J Biol Chem 266:484-489.
29. Kinouchi K, Brown G, Pasternak G, Donner D (1991): Identification and characterization of receptors for tumor necrosis factor-alpha in the brain. Biochem Biophys Res Commun 181:1532-1538.
30. Klinkert WEF, Kojima K, Lesslauer W, Rinner W, Lassmann H, Wekerle H (1997): TNF-α receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overview. J Neuroimmunol 72:163-168.
31. Kolesnick R, Golde DW (1994): The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77:325-328.
32. Kunishita T, Ledeen RW (1984): Phospholipid biosynthesis in myelin: presence of CTP:phosphoethanolamine cytidylyltransferase in purified myelin of rat brain. J Neurochem 42:326-333.
33. Laemmli UK (1970): Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
34. Larocca JN, Ledeen RW, Dvorkin B, Makman MH (1987a): Muscarinic receptor binding and muscarinic receptor-mediated inhibition of adenylate cyclase in rat brain myelin. J Neurosci 7:3863-3876.
35. Larocca JN, Cervone A, Ledeen RW (1987b): Stimulation of phosphoinositide hydrolysis in myelin by muscarinic agonist and potassium. Brain Res 436:357-362.
36. Larocca JN, Golly F, Ledeen RW (1991): Detection of G proteins in purified bovine brain myelin. J Neurochem 57:30-38.
37. Lassmann H, Vass K (1995): Are current immunological concepts of multiple sclerosis reflected by immunopathology of its lesions? Semin Immunopathol (Springer) 17:77-87.
38. Ledeen RW (1992): Enzymes and receptors of myelin. In Martenson RE (ed): "Myelin Biology and Chemistry." Boca Raton, FL: CRC Press, pp 531-570.
39. Ledeen RW, Chakraborty G (in press): Cytokines, signal transduction and inflammatory demyelination: review and hypothesis. Neurochem Res.
40. Ledeen RW, Yu RK (1982): Gangliosides: structure, isolation and analysis. Methods Enzymol 83:139-191.
41. Lees MB, Paxman S (1972): Modification of the Lown procedure for the analysis of proteolipid protein. Analyt Biochem 47:184-192.
42. Lewis M, Tartaglia LA, Lee A, Bennett GL, Rice GC, Wong GHW, Chen EY, Goeddel DV (1991): Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci USA 88:2830-2834.
43. Mathias S, Younes A, Kan C-C, Orlow I, Joseph C, Kolesnick RN (1993): Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1β. Science 259:519-522.
44. Merrill JE, Benveniste EN (1996): Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci 19:331-338.
45. Norton WT, Poduslo S (1973): Myelination in rat brain: method of myelin isolation. J Neurochem 21: 748-751.
46. Obeid LM, Hannun YA (1995): Ceramide: a stress signal and mediator of growth suppression and apoptosis. J Cell Biochem 58:191-198.
47. 3-induced HL-60 cell differentiation. J Biol Chem 269:4070-4077.
48. Ozawa K, Suchanek G, Breitschopf H, Bruck W, Budka H, Jellinger K, Lassmann H (1994): Patterns of oligodendroglial pathology in multiple sclerosis. Brain 117:1311-1322.
49. Probert L, Akassoglou K, Pasparakis M, Kontogeorgos G, Kollias G (1995): Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor α. Proc Natl Acad Sci USA 92:11294-11298.
50. Ryffel B, Mihatsch MJ (1993): TNF receptor distribution in human tissues. Int Rev Exp Pathol 34B:149-156.
51. Saltiel AR, Fox JA, Sherline P, Sahyoun N, Cuatrecasas P (1987): Purification of phosphatidylinositol kinase from bovine brain myelin. Biochem J 241:759-763.
52. Schneider PB, Kennedy EP (1967): Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease. J Lipid Res 8:202-209.
53. Selmaj KW, Raine CS (1988): Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23:339-346.
54. Shaikh NA, Palmer FBSC (1976): Deposition of lipids in the developing central and peripheral nervous systems of the chicken. J Neurochem 26:597-603.
55. Sheehan KCF, Pinkard JK, Arthur CD, Dehner LP, Goeddel DV, Schreiber RD (1995): Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification fora novel in vivo role for p75. J Exp Med 181:607-617.
56. Vos JP, Giudici ML, van der Bijl P, Magni P, Marchesini S, van Golde LMG, Lopes-Cardozo M (1995): Sphingomyelin is synthesized at the plasma membrane of oligodendrocytes and by purified myelin membranes: a study with fluorescent- and radiolabeled ceramide analogues. FEBS Lett 368:393-396.
57. Yamaguchi S, Suzuki K (1978): A novel magnesium-independent neutral sphingomyelinase associated with rat central nervous system myelin. J Biol Chem 253:4090-4092.
58. Yamanaka T, Hanada E, Suzuki K (1981): Acid sphingomyelinase in human brain; improved purification procedures and characterization. J Biol Chem 256:3884-3889.
59. Yohe HC, Saito M, Ledeen RW, Kunishita T, Sclafani JR, Yu RK (1986): Further evidence for an intrinsic neuraminidase in CNS myelin. J Neurochem 46:623-629.
60. 2+-dependent neutral sphingomyelinase in CNS myelin. J Neurochem 66 (Suppl):S46C.